Cost-effectiveness analysis of HLA-B*15:02 screening before treatment of epilepsy in Indonesia

CONCLUSION: Calculation of the cost-effectiveness of lifetime epilepsy therapy in this study found that the initial screening strategy with the HLA-B*15:02 test was the most cost-effective.PMID:38657484 | DOI:10.1016/j.yebeh.2024.109787

Source: Epilepsy and Behaviour - April 24, 2024 Category: Neurology Authors: Eric Tanoto Herlyani Khosama Seilly Jehosua Sekplin A S Sekeon Winifred Karema Arthur H P Mawuntu Fima F L G Langi Lim Kheng Seang Source Type: research